European Urology Open Science · 2021 · 12 citations · 7 references
MedicineSurgeryUrologyGenitourinary OncologySurgical OncologyUrologic SurgeryGenitourinary Cancer SurgeryPartial NephrectomyRadical CystectomyUrologic Oncology SurgerySurgical Skill TrainingSurgical TrainingUrological Complications
COVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with a high risk of progression. We report outcomes for major GU cancer operations, namely radical prostatectomy (RP), radical cystectomy (RC), radical nephrectomy (RN), partial nephrectomy (PN), and nephroureterectomy performed at 13 major GU cancer centres across the UK between March 1 and May 5, 2020. A total of 598 such operations were performed. Four patients (0.7%) developed COVID-19 postoperatively. There was no COVID-19–related mortality at 30 d. A minimally invasive approach was used in 499 cases (83.4%). A total of 228 cases (38.1%) were described as training procedures. Training case status was not associated with a higher American Society of Anesthesiologists (ASA) score (p = 0.194) or hospital length of stay (LOS; p > 0.05 for all operation types). The risk of contracting COVID-19 was not associated with longer hospital LOS (p = 0.146), training case status (p = 0.588), higher ASA score (p = 0.295), or type of hospital site (p = 0.303). Our results suggest that major surgery for urological cancers remains safe and training should be encouraged during the ongoing COVID-19 pandemic provided appropriate countermeasures are taken. These real-life data are important for policy-makers and clinicians when counselling patients during the current pandemic. We collected outcome data for major operations for prostate, bladder, and kidney cancers during the COVID-19 pandemic. These surgeries remain safe and training should be encouraged during the ongoing pandemic provided appropriate countermeasures are taken. Our real-life results are important for policy-makers and clinicians when counselling patients during the COVID-19 pandemic.
7
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J. Alfred Witjes, Thierry Lebrét, Éva Compérat et al. · European Urology · 2016 · 1.5K citations
Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk
Glenn N. Levine, Anthony V. D’Amico, Peter Berger et al. · Circulation · 2010 · 376 citations · Full text
María J. Ribal, Philip Cornford, Alberto Briganti et al. · European Urology · 2020 · 313 citations · Full text